Exponential Growth 2021 to Date | One of Europe's leading biopharmaceutical companies

Opportunity to invest in GROWTM One of Europe’s leading biopharmaceutical companies specialising in cannabis-based medicines [Grow Group Image]( Want to speak with one of our team? [Click Here]( to organise a call Why GROW now? Exponential Growth 2021 to Date - Vertically integrated medical cannabis company with ambitions to be a global leader - Grow Pharma now profitable in the UK - Revenues already over £3.5m million for 2021 - Grow doubled in revenue between 2019 and 2020, and doubled again by June 2021 - Exclusive UK distribution partnerships with global leading brands including Tilray and Columbia Care - Expanding domestically and internationally - Recently acquired Sanoid, one of the first licensed Cannabis production facilities in Spain, capable of producing up to 20 tons of medical cannabis a year. - Proprietary cannabis technologies under 100% owned patents which deliver on low-cost and high-quality cannabinoids. [As Seen In]( To invest today [Click Here]( Investment will help us continue to unlock the potential of cannabis medicines Our goal is to be the largest provider of medical cannabis in patient numbers by 2025. [Ben Langley, CEO]( Ben Langley, CEO "The patient is at the heart of everything we do. Our company is promising to deliver on this by making affordable and accessible cannabis medicines available to all." We have a £6m round open of which over £4m has been raised. Funding will be used for: - Expansion into Germany - Commercialisation of our patented R&D technologies - Capital expenditure into processing and extraction facility in Spain Meet the team behind getting patients access to cannabis-based medicines. [Click Here]( [Grow Group Logo]( Disclaimer: Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Investment is only available to High-Net-Worth Investors or Sophisticated Investors. Please remember that financial investments may rise or fall, and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested. You should always seek advice from a regulated financial advisory before making any investment. ADVFN Disclaimer Although ADVFN has sent you this email on behalf of an advertiser, this is not an ADVFN product. ADVFN does not endorse this product or the company providing it nor is it responsible for the content of this advertisement. We have not reviewed the information; claims or testimonials provided within the advertisement and make no guarantee or warranty regarding its content. The opinions and recommendations expressed in this email advertisement are not those of ADVFN and ADVFN offers none in any event. --------------------------------------------------------------- [View Online]( [Add us to your address book]( [Unsubscribe]( from ADVFN commercial emails --------------------------------------------------------------- Registered Office/Accounts Dept: 28 Ongar Business Centre, The Gables, Fyfield Road, Ongar, Essex, CM5 0GA. Support Tel: +44 (0) 203 8794 460 Company registered in England and Wales: Number 2374988 VAT No: GB 549 2130 49